Claudia Traidl-Hoffmann, Jamie Afghani, Cezmi A Akdis, Mübecel Akdis, Handan Aydin, Katja Bärenfaller, Heidrun Behrendt, Thomas Bieber, Paul Bigliardi, Mei Bigliardi-Qi, Charlotte Menné Bonefeld, Stefanie Bösch, Marie Charlotte Brüggen, Sebastian Diemert, Hans-Werner Duchna, Martina Fähndrich, Danielle Fehr, Marc Fellmann, Remo Frei, Lena H Garvey, Raschid Gharbo, Mehmet Gökkaya, Karin Grando, Carole Guillet, Erman Guler, Jan Gutermuth, Nadine Herrmann, Dirk Jan Hijnen, Claudia Hülpüsch, Alan D Irvine, Erika Jensen-Jarolim, Heidi H Kong, Hillel Koren, Claudia C V Lang, Roger Lauener, Laura Maintz, Pierre-Yves Mantel, Emanuel Maverakis, Matthias Möhrenschlager, Svenja Müller, Kari Nadeau, Avidan U Neumann, Liam O'Mahony, Fahafahantsoa Rapelanoro Rabenja, Harald Renz, Claudio Rhyner, Ernst Rietschel, Johannes Ring, Caroline Roduit, Mari Sasaki, Mirjam Schenk, Jens Schröder, Dagmar Simon, Hans-Uwe Simon, Milena Sokolowska, Sonja Ständer, Martin Steinhoff, Doris Straub Piccirillo, Alain Taïeb, Roberto Takaoka, Martin Tapparo, Henrique Teixeira, Jacob Pontoppidan Thyssen, Stephan Traidl, Miriam Uhlmann, Willem van de Veen, Marianne van Hage, Christian Virchow, Andreas Wollenberg, Mitamura Yasutaka, Alexander Zink, Peter Schmid-Grendelmeier
{"title":"Navigating the evolving landscape of atopic dermatitis: Challenges and future opportunities: The 4th Davos declaration.","authors":"Claudia Traidl-Hoffmann, Jamie Afghani, Cezmi A Akdis, Mübecel Akdis, Handan Aydin, Katja Bärenfaller, Heidrun Behrendt, Thomas Bieber, Paul Bigliardi, Mei Bigliardi-Qi, Charlotte Menné Bonefeld, Stefanie Bösch, Marie Charlotte Brüggen, Sebastian Diemert, Hans-Werner Duchna, Martina Fähndrich, Danielle Fehr, Marc Fellmann, Remo Frei, Lena H Garvey, Raschid Gharbo, Mehmet Gökkaya, Karin Grando, Carole Guillet, Erman Guler, Jan Gutermuth, Nadine Herrmann, Dirk Jan Hijnen, Claudia Hülpüsch, Alan D Irvine, Erika Jensen-Jarolim, Heidi H Kong, Hillel Koren, Claudia C V Lang, Roger Lauener, Laura Maintz, Pierre-Yves Mantel, Emanuel Maverakis, Matthias Möhrenschlager, Svenja Müller, Kari Nadeau, Avidan U Neumann, Liam O'Mahony, Fahafahantsoa Rapelanoro Rabenja, Harald Renz, Claudio Rhyner, Ernst Rietschel, Johannes Ring, Caroline Roduit, Mari Sasaki, Mirjam Schenk, Jens Schröder, Dagmar Simon, Hans-Uwe Simon, Milena Sokolowska, Sonja Ständer, Martin Steinhoff, Doris Straub Piccirillo, Alain Taïeb, Roberto Takaoka, Martin Tapparo, Henrique Teixeira, Jacob Pontoppidan Thyssen, Stephan Traidl, Miriam Uhlmann, Willem van de Veen, Marianne van Hage, Christian Virchow, Andreas Wollenberg, Mitamura Yasutaka, Alexander Zink, Peter Schmid-Grendelmeier","doi":"10.1111/all.16247","DOIUrl":null,"url":null,"abstract":"<p><p>The 4th Davos Declaration was developed during the Global Allergy Forum in Davos which aimed to elevate the care of patients with atopic dermatitis (AD) by uniting experts and stakeholders. The forum addressed the high prevalence of AD, with a strategic focus on advancing research, treatment, and management to meet the evolving challenges in the field. This multidisciplinary forum brought together top leaders from research, clinical practice, policy, and patient advocacy to discuss the critical aspects of AD, including neuroimmunology, environmental factors, comorbidities, and breakthroughs in prevention, diagnosis, and treatment. The discussions were geared towards fostering a collaborative approach to integrate these advancements into practical, patient-centric care. The forum underlined the mounting burden of AD, attributing it to significant environmental and lifestyle changes. It acknowledged the progress in understanding AD and in developing targeted therapies but recognized a gap in translating these innovations into clinical practice. Emphasis was placed on the need for enhanced awareness, education, and stakeholder engagement to address this gap effectively and to consider environmental and lifestyle factors in a comprehensive disease management strategy. The 4th Davos Declaration marks a significant milestone in the journey to improve care for people with AD. By promoting a holistic approach that combines research, education, and clinical application, the Forum sets a roadmap for stakeholders to collaborate to improve patient outcomes in AD, reflecting a commitment to adapt and respond to the dynamic challenges of AD in a changing world.</p>","PeriodicalId":122,"journal":{"name":"Allergy","volume":null,"pages":null},"PeriodicalIF":12.6000,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Allergy","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/all.16247","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/8/4 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"ALLERGY","Score":null,"Total":0}
引用次数: 0
Abstract
The 4th Davos Declaration was developed during the Global Allergy Forum in Davos which aimed to elevate the care of patients with atopic dermatitis (AD) by uniting experts and stakeholders. The forum addressed the high prevalence of AD, with a strategic focus on advancing research, treatment, and management to meet the evolving challenges in the field. This multidisciplinary forum brought together top leaders from research, clinical practice, policy, and patient advocacy to discuss the critical aspects of AD, including neuroimmunology, environmental factors, comorbidities, and breakthroughs in prevention, diagnosis, and treatment. The discussions were geared towards fostering a collaborative approach to integrate these advancements into practical, patient-centric care. The forum underlined the mounting burden of AD, attributing it to significant environmental and lifestyle changes. It acknowledged the progress in understanding AD and in developing targeted therapies but recognized a gap in translating these innovations into clinical practice. Emphasis was placed on the need for enhanced awareness, education, and stakeholder engagement to address this gap effectively and to consider environmental and lifestyle factors in a comprehensive disease management strategy. The 4th Davos Declaration marks a significant milestone in the journey to improve care for people with AD. By promoting a holistic approach that combines research, education, and clinical application, the Forum sets a roadmap for stakeholders to collaborate to improve patient outcomes in AD, reflecting a commitment to adapt and respond to the dynamic challenges of AD in a changing world.
第四届达沃斯宣言是在达沃斯全球过敏论坛期间制定的,该论坛旨在通过联合专家和利益相关方,提升特应性皮炎(AD)患者的护理水平。论坛探讨了特应性皮炎的高发病率问题,其战略重点是推进研究、治疗和管理,以应对该领域不断变化的挑战。这次多学科论坛汇聚了来自研究、临床实践、政策和患者权益倡导等领域的顶级领导者,共同探讨了 AD 的关键问题,包括神经免疫学、环境因素、合并症以及预防、诊断和治疗方面的突破。讨论的目的是促进合作,将这些进展融入以患者为中心的实用护理中。论坛强调了注意力缺失症带来的日益沉重的负担,并将其归因于环境和生活方式的重大改变。论坛承认在了解注意力缺失症和开发针对性疗法方面取得了进展,但也认识到在将这些创新成果转化为临床实践方面还存在差距。宣言强调需要加强认识、教育和利益相关者的参与,以有效弥补这一差距,并在全面的疾病管理战略中考虑环境和生活方式因素。第四届达沃斯宣言是改善对注意力缺失症患者护理的一个重要里程碑。通过推广一种将研究、教育和临床应用相结合的整体方法,论坛为利益相关者制定了合作改善注意力缺失症患者治疗效果的路线图,体现了在不断变化的世界中适应和应对注意力缺失症动态挑战的承诺。
期刊介绍:
Allergy is an international and multidisciplinary journal that aims to advance, impact, and communicate all aspects of the discipline of Allergy/Immunology. It publishes original articles, reviews, position papers, guidelines, editorials, news and commentaries, letters to the editors, and correspondences. The journal accepts articles based on their scientific merit and quality.
Allergy seeks to maintain contact between basic and clinical Allergy/Immunology and encourages contributions from contributors and readers from all countries. In addition to its publication, Allergy also provides abstracting and indexing information. Some of the databases that include Allergy abstracts are Abstracts on Hygiene & Communicable Disease, Academic Search Alumni Edition, AgBiotech News & Information, AGRICOLA Database, Biological Abstracts, PubMed Dietary Supplement Subset, and Global Health, among others.